Searched for
CISPLATIN
API prices fall as West Asia tensions ease, boosting Indian pharma sectorPrices for active pharmaceutical ingredients have seen a decline of five to ten percent, thanks to the calming geopolitical climate in West...- India raises price cap on cancer drugs to tackle shortageIndia's drug price regulator has increased the ceiling prices of cancer drugs cisplatin and carboplatin by 50% to tackle shortages caused b...
- Cancer drug prices raised 50% as NPPA acts on shortage concernsIndia's drug pricing authority has approved a 50% price hike for essential anti-cancer drugs carboplatin and cisplatin. This decision follo...
- Government may lift price cap on cancer drugs making them costlier by up to 50%India's government is taking emergency steps to ensure cancer patients get vital drugs. Cisplatin and carboplatin, crucial chemotherapy age...
- Indian cancer patients battle shortage of key drugs as platinum costs surgeCancer patients in India are struggling to find essential platinum-based drugs. A surge in global platinum prices and supply chain issues a...
- Regulator, cos discuss price hike for some cancer drugsIndia's drug pricing authority may soon approve a price hike for vital platinum-based cancer medicines. These drugs, including carboplatin ...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Cancer drug makers seek 50% price hike as platinum surge hits production viabilityLocal drug manufacturers are struggling to produce essential cancer medicines like carboplatin and cisplatin due to a significant surge in ...
- Dr Reddy's Laboratories shares rise 2% after launching drug to treat nasopharyngeal cancerDr Reddy's Laboratories has launched toripalimab, an immune oncology drug for adults with recurrent or metastatic nasopharyngeal carcinoma ...
- Dr Reddy's launches drug for neck, head cancerDr Reddy's Laboratories launched toripalimab, an immune oncology drug for adults with a rare form of head and neck cancer, in India. This d...
- Dr Reddy's launches novel cancer therapy Toripalimab in IndiaDr. Reddy’s has launched Toripalimab, a novel immuno-oncology drug, in India for treating recurrent or metastatic nasopharyngeal carcinoma ...
- Venus Remedies gets marketing approval for six chemotherapy drugs from PhilippinesVenus Remedies has already submitted dossiers to the Health Ministry of the Philippines for additional 45 marketing authorisations, and mos...
- Alembic Pharma gets USFDA nod for generic injection to treat cancerThe approval granted by the US Food & Drug Administration (USFDA) is for the abbreviated new drug application (ANDA) for Paclitaxel injecti...
- Cyca Onco's precision delivery of chemotherapy medication bags tech awardIll effects of chemotherapy to combat cancer can be drastically reduced if the medication is administered in a precise and targeted manner.
- Cheap drug for common cold can stop spread of cancerTokyo, Oct 18 (IANS) A non-steroid, anti-inflammatory drug used for treating common cold has the potential to suppress the spread of bladde...
- Claris receives US approval for two drugsClaris Lifesciences received approval for Ondensetron Injection used in prevention of nausea and vomiting during cancer chemotherapy.
- Taking the toxin out of your cancer treatmentRA Sengupta and Shiladitya Mashelkar have set up a Delhi-based co, Invictus Oncology, to take a modified Cisplatin to the market.
- Strides Arcolab surge to record high on cancer drug approvalShares of drug maker Strides Arcolab today surged to a record high after the company received approval from the US health regulator to sell...
- Strides Arcolab gets USFDA nod for cancer injection CisplatinStrides Arcolab said it has received approval from the USFDA to sell generic version of Cisplatin injection used in cancer treatment.
- Sun Pharma gets USFDA approval to market generic EthyolSun Pharmaceutical Industries has received approval from USFDA for abbreviated new drug application of amifostine for injection 500mg.
Load More
